BrainsWay Ltd. (TLV:BWAY)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,726.00
-47.00 (-2.65%)
Mar 30, 2025, 10:16 AM IDT
70.05%
Market Cap 642.01M
Revenue (ttm) 149.39M
Net Income (ttm) 10.64M
Shares Out 37.63M
EPS (ttm) 0.33
PE Ratio 52.04
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,584
Average Volume 47,213
Open 1,773.00
Previous Close 1,773.00
Day's Range 1,715.00 - 1,773.00
52-Week Range 934.70 - 2,080.00
Beta 0.44
RSI 45.81
Earnings Date Mar 20, 2025

About BrainsWay

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves do... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 134
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BWAY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript

BrainsWay Ltd. (NASDAQ:BWAY) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Hadar Levy - Chief Executive Officer ...

19 days ago - Seeking Alpha

BrainsWay GAAP EPS of $0.04 beats by $0.02, revenue of $11.41M beats by $0.52M

BrainsWay reports Q4 GAAP EPS of $0.04, revenue up 26.4% Y/Y, and strong 2025 guidance. Growth in Deep TMS™ adoption driving profitability.

19 days ago - Seeking Alpha

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Achieved r ecord quarterly s ales of $11.4 million in Q4 2024 , an increase of 27% compared with Q4 2023

19 days ago - GlobeNewsWire

Earnings Scheduled For March 11, 2025

Companies Reporting Before The Bell • Exagen (NASDAQ: XGN) is projected to report quarterly loss at $0.24 per share on revenue of $13.85 million. • Core Molding Technologies (AMEX: CMT) is expected ...

19 days ago - Benzinga

BrainsWay Q4 2024 Earnings Preview

20 days ago - Seeking Alpha

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain ...

3 months ago - GlobeNewsWire

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd.

4 months ago - GlobeNewsWire

BrainsWay: Cash Flow Doubts Weigh On The Stock

BrainsWay reported strong growth in the third quarter and gave solid guidance. Click here to read my analysis of BWAY stock.

4 months ago - Seeking Alpha

BrainsWay Ltd. (BWAY) Q3 2024 Earnings Call Transcript

BrainsWay Ltd. (NASDAQ:BWAY) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call P...

4 months ago - Seeking Alpha

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance Conference Call to be Held Today at 8:30 AM ET BURLI...

4 months ago - GlobeNewsWire

Earnings Scheduled For November 12, 2024

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ: TIGR) is likely to report quarterly earnings at $0.13 per share on revenue of $98.00 million. • PLDT (NYSE: PHI) is likely to report...

4 months ago - Benzinga

BrainsWay Q3 Earnings Preview

4 months ago - Seeking Alpha

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatme...

5 months ago - GlobeNewsWire

Are Medical Stocks Lagging Brainsway This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY) been one of thos...

5 months ago - Benzinga

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...

6 months ago - GlobeNewsWire

BrainsWay: More Cash, More Uncertainty

6 months ago - Seeking Alpha

What's Going On With BrainsWay Shares Monday?

BrainsWay Ltd. (NASDAQ: BWAY) stock is trading higher on Monday after the company announced a $20 million investment from Valor Equity Partners. The Details: BrainsWay will issue a total of 2,103,745...

6 months ago - Benzinga

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

Company to leverage capital and Valor's expertise for strategic initiatives building market awareness, R&D roadmap, data analysis capabilities, and expanding access to Deep TMS™

6 months ago - GlobeNewsWire

BrainsWay Announces Significant Expansion on U.S. East Coast

BURLINGTON, Mass. and JERUSALEM, Sept.

6 months ago - GlobeNewsWire

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

BURLINGTON, Mass. and JERUSALEM, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulatio...

7 months ago - GlobeNewsWire

BrainsWay appoints Richard Bermudes, M.D. as CMO

BrainsWay (BWAY) has announced the appointment of Richard A. Bermudes, M.D. as Chief Medical Officer, effective Sept. 1, 2024

7 months ago - Seeking Alpha

BrainsWay Appoints Richard A. Bermudes, M.D.

Dr. Bermudes is Widely Considered One of the Preeminent U.S. Clinicians in the TMS Field Dr. Bermudes is Widely Considered One of the Preeminent U.S. Clinicians in the TMS Field

7 months ago - GlobeNewsWire

BrainsWay Ltd. (BWAY) Q2 2024 Earnings Call Transcript

BrainsWay Ltd. (NASDAQ:BWAY) Q2 2024 Earnings Call Transcript August 6, 2024 8:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Part...

8 months ago - Seeking Alpha